The US Food and Drug Administration (FDA) has approved the first generic versions of Suboxone (buprenorphine and naloxone) sublingual film for the treatment of opioid dependence, which may increase ...
No difference was detected in opioid use disorder treatment engagement on day 7 between the 7-day extended-release and sublingual ...
Buprenorphine sublingual tablet is a generic prescription drug that’s used to help treat opioid dependence (also known as opioid use disorder). The buprenorphine tablet does not come in a brand-name ...
Disclosures: Compton reports having stock holdings in 3M, General Electric and Pfizer outside of the invited commentary. Lintzeris reports serving on advisory boards for GW Pharmaceuticals, Indivior ...
RICHMOND, Va., Aug. 20, 2012 /PRNewswire/ -- Reckitt Benckiser Pharmaceuticals Inc. today announced the U.S. Food and Drug Administration (FDA) approval of the 4 mg and 12 mg doses of Suboxone ® ...
SAN FRANCISCO (KRON) — As California struggles to stem a tragic tide of fatal fentanyl overdoses, a global pharmaceutical company will pay more than $100 million for allegedly stifling access to ...
Click to share on Facebook (Opens in new window) Click to share on X (Opens in new window) Click to email a link to a friend (Opens in new window) Click to share on LinkedIn (Opens in new window) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results